Costs, throughput time, and proportion of valid test results, a model-based analysis of liquid biopsies for stage IV non-small cell lung cancer.

被引：0
|
作者：
Koole, Simone N.
Schouten, Robert
Vessies, Daan
Schuurbiers, Milou
Bosch, Linda J. W.
van den Heuvel, Michel
van Harten, Wim
van den Broek, Daan
Monkhorst, Kim
Retel, Valesca P.
机构：
[1] Netherlands Canc Inst, Dept Hlth Econ, Amsterdam, Netherlands
[2] Netherlands Canc Inst, Amsterdam, Netherlands
[3] Radboud Univ, Med Ctr, Nijmegen, Netherlands
[4] Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands
[5] RadboudUMC, Dept Thorac Oncol, Nijmegen, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e18844
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18844
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Surgical treatment of stage IV non-small cell lung cancer
    Kawano, Daigo
    Takeo, Sadanori
    Katsura, Masakazu
    Tsukamoto, Shuichi
    Masuyama, Eri
    Nakaji, Yu
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2012, 14 (02) : 167 - 170
  • [22] Salvage Surgery for Stage IV Non-Small Cell Lung Cancer
    Kojima, Hideaki
    Hayashi, Shoko
    Mizuno, Kiyomichi
    Yasuura, Yoshiyuki
    Shimizu, Reiko
    Kayata, Hiroyuki
    Takahashi, Shoji
    Isaka, Mitsuhiro
    Takahashi, Toshiaki
    Ohde, Yasuhisa
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S777 - S777
  • [23] Chemotherapeutic management of stage IV non-small cell lung cancer
    Socinski, MA
    Morris, DE
    Masters, GA
    Lilenbaum, R
    CHEST, 2003, 123 (01) : 226S - 243S
  • [24] The utility of liquid biopsies for management of stage IV non-small cell lung cancer (NSCLC) in an academic community medical center.
    Maity, Alisha Paro
    Gangireddy, Mounika
    Dessain, Scott K.
    Evans, Tracey L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [25] Editorial: KRAS in stage IV non-small cell lung cancer
    Noordhof, Anneloes L.
    Blum, Torsten Gerriet
    Hardavella, Georgia
    Hendriks, Lizza E. L.
    van Geffen, Wouter H.
    FRONTIERS IN ONCOLOGY, 2025, 14
  • [26] Extending Survival of Stage IV Non-Small Cell Lung Cancer
    Carnio, Simona
    Novello, Silvia
    Mele, Teresa
    Levra, Matteo Giaj
    Scagliotti, Giorgio Vittorio
    SEMINARS IN ONCOLOGY, 2014, 41 (01) : 69 - 92
  • [27] Is survival improving in stage IV non-small cell lung cancer?
    Birnbaum, A. E.
    Ng, T.
    O'Connor, B.
    Plette, A.
    Berz, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [28] Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance
    Koole, Simone N.
    Vessies, Daan C. L.
    Schuurbiers, Milou M. F.
    Kramer, Astrid
    Schouten, Robert D.
    Degeling, Koen
    Bosch, Linda J. W.
    van den Heuvel, Michel M.
    van Harten, Wim H.
    van den Broek, Daan
    Monkhorst, Kim
    Retel, Valesca P.
    CANCERS, 2022, 14 (07)
  • [29] Stage JIIB non-small cell lung cancer. Is there a recommended treatment?
    Fournel, P.
    REVUE DES MALADIES RESPIRATOIRES, 2006, 23 (05) : S54 - S60
  • [30] Effect of delaying chemotherapy on survival outcomes in the treatment of stage IV non-small cell lung cancer.
    Mozayen, Mohammad
    Alsharedi, Mohamed Farouq
    Mehmi, Inderjit
    Gress, Todd W.
    Tirona, Maria R. B. Tria
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345